daratumumab,pomalidomide,ciltacabtagene autoleucel,dexamethasone,bortezomib
janssen
['cartitude', 'cartitude-4', 'rafael ']
 yes, watching the plenary session at eha23, especially with the results of cartitude-4. how does that sound?
Chief Innovation Officer - Mayo Clinic in Arizona. Myeloma doctor. Visiting Healthcare Fellow @GoldwaterInst. Tweets-own/RT not an endorsement